Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortOral prodrug of ganciclovir for CMV treatment and prevention.IV antiviral for CMV infection in transplant and HIV patients.
Body systemAntiviralsAntivirals
Drug classNucleoside analogues (herpes)Nucleoside analogues (herpes)
SupplyPrescription onlyPrescription only
Main usesCMV prevention after transplant, CMV retinitis, Congenital CMV (specialist)CMV retinitis, CMV disease in transplant recipients, CMV prevention after transplant
How it worksStops cytomegalovirus from multiplying.Stops cytomegalovirus from multiplying.
Starts workingDaysDays
Half-lifeAbout 4 hours2–4 hours
Typical adult dose900 mg twice a day for induction, then 900 mg once a day for maintenance or prevention.5 mg/kg IV every 12 hours for induction, then once daily for maintenance.
FormsTablet, Oral solutionIV infusion
Common side effectsDiarrhoea, Nausea, Low white cells, HeadacheFever, Low blood counts, Nausea, Diarrhoea
Serious side effectsSevere neutropenia and anaemia, Low platelets, Seizures, Birth defectsSevere neutropenia and anaemia, Low platelets, Seizures, Birth defects
Don't take ifVery low blood counts; Pregnancy; BreastfeedingVery low neutrophil or platelet counts; Pregnancy; Allergy to aciclovir (cross-reactivity)
AlcoholBest to limit. Alcohol may worsen nausea.Usually no problem in moderation. Not directly relevant.
PregnancyUsually avoidedHarmful to the baby.Usually avoidedHarmful to the baby; avoid unless life-threatening.
BreastfeedingUsually avoidedAvoid.Usually avoidedAvoid.
In use since——
Brand namesUnited States: ValcyteUnited Kingdom: ValcyteIndia: Valcyte, ValcytUnited States: CytoveneUnited Kingdom: CymeveneIndia: Cytovene, Ganciclovir (generic)
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H
ATC codeJ05AB14J05AB06

Taken together

  • ModerateValganciclovir + Ganciclovir: Added bone marrow suppression

    Both can lower white cells, red cells or platelets; together the risk of infection and bleeding rises.

Open in the interaction checker